The Government will invest an extra £2m in the latest phase of the Public Health England (PHE) antibiotics campaign.
Health secretary Matt Hancock announced the new measures this week, including the development of a new payment system to incentivise pharmaceutical companies to invest in drug development, to drive down the use of antibiotics.
Related Article: GPhC to go ahead with 6% fee increase from September
The latest phase of PHE's Keep Antibiotics Working campaign, which was first launched in 2017, is set to start in October and will see a £2m funding injection to educate the public on how to best use antibiotics.
Under Government plans, the introduction of a subscription-like model for pharmaceutical companies means they will receive upfront payments for medicines based on their usefulness to the NHS, rather than based on the number of antibiotics they sell.
It is hoped this new approach will put a stop to the current situation, which encourages companies to produce higher volumes when NHS England is trying to reduce antibiotics use in a bid to address antimicrobial resistance.
Related Article: MPs to examine NHS use of weight loss injections in obesity inquiry
Health secretary Matt Hancock said: 'There is no greater threat to global health than drug-resistant infections, yet there have been no major new antibiotic drug classes discovered since the 1980s. Imagine a world in which a papercut can lead to infection that can't be controlled. We must stop that from happening. Tackling superbugs needs global leadership and peoples’ lives depend on us finding a new way forward.'
He added: 'Our NHS is in a unique position to take a global lead in testing new payment models. We will take the lead but this is a global problem and we cannot succeed alone. I am proud the UK is taking the first steps towards a solution and I am urging the rest of the world to join us in the fight against superbugs.'
Related Article: Xarelto pack sizes changed following discrepancies identified by CPE
The Government recently shared its 20-year vision and five-year national action plan setting out how the UK will contribute to containing and controlling antimicrobial resistance by 2040.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.